Search Results - Mark R. Litzow
- Showing 1 - 20 results of 44
- Go to Next Page
-
1
-
2
The origins of the definition of complete remission in acute myeloid leukemia by Mark R. Litzow
Published in Haematologica (2025-02-01)Get full text
Article -
3
The real world of acute lymphoblastic leukemia by Mark R. Litzow
Published in Haematologica (2024-09-01)Get full text
Article -
4
-
5
Inhibition of the mutated c-KIT kinase in AML1-ETO–positive leukemia cells restores sensitivity to PARP inhibitor by Margaret Nieborowska-Skorska, Elisabeth M. Paietta, Ross L. Levine, Hugo F. Fernandez, Martin S. Tallman, Mark R. Litzow, Tomasz Skorski
Published in Blood Advances (2019-12-01)Get full text
Article -
6
Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant by Ayalew Tefferi, Animesh Pardanani, Kebede H. Begna, Aref Al-Kali, William J. Hogan, Mark R. Litzow, Rhett P. Ketterling, Kaaren K. Reichard, Naseema Gangat
Published in Blood Cancer Journal (2024-03-01)Get full text
Article -
7
Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy by Naseema Gangat, Rimal Ilyas, Isla M Johnson, Kristen McCullough, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek Mangaonkar, Mark R Litzow, William Hogan, Mithun Shah, Mrinal M Patnaik, Animesh Pardanani, Ayalew Tefferi
Published in Haematologica (2023-03-01)Get full text
Article -
8
Patient-centered care strategies for Jehovah's Witnesses with acute leukemia and high-grade myeloid neoplasms by Jabra Zarka, Aref Al-Kali, Hassan B. Alkhateeb, Aasiya Matin, Naseema Gangat, William J. Hogan, James Foran, Hemant Murthy, Cecilia Arana Yi, Dhauna Karam Prasad, Syeda Mina, Mark R. Litzow, Kebede H. Begna, Antoine N. Saliba
Published in Haematologica (2025-10-01)Get full text
Article -
9
Molecular predictors of response and survival in patients with relapsed/refractory acute myeloid leukemia following venetoclax plus hypomethylating agent therapy by Isla M. Johnson, Rimal Ilyas, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede H. Begna, Abhishek Mangaonkar, Antoine Saliba, Mark R. Litzow, William Hogan, Mithun Shah, Mrinal M. Patnaik, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
Published in Haematologica (2025-02-01)Get full text
Article -
10
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B‐cell or T‐cell acute lymphoblastic leukemia: Results from the ECOG... by Neil D. Palmisiano, Ju‐Whei Lee, David F. Claxton, Elisabeth M. Paietta, Hassan Alkhateeb, Jae Park, Nikolai A. Podoltsev, Ehab L. Atallah, Dale G. Schaar, Shira N. Dinner, Jonathan A. Webster, Selina M. Luger, Mark R. Litzow
Published in eJHaem (2024-10-01)Get full text
Article -
11
Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience by Ayalew Tefferi, Naseema Gangat, Mithun Shah, Hassan Alkhateeb, Mrinal S. Patnaik, Aref Al-Kali, Michelle A. Elliott, William J. Hogan, Mark R. Litzow, Christopher C. Hook, Abhishek Mangaonkar, David Viswanatha, Dong Chen, Animesh Pardanani, Rhett P. Ketterling, Kebede H. Begna
Published in Haematologica (2022-06-01)Get full text
Article -
12
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malig... by Samuel J. Yates, Julian J. Weiss, Abigail Sneider, Emily Geramita, Guru Subramanian Guru Murthy, Talha Badar, Annie Im, Chenyu Lin, Wei Cheng, Yasmin Abaza, Alok Swaroop, Eric S. Winer, Mark R. Litzow, Ehab L. Atallah, Anand Ashwin Patel, Rory M. Shallis
Published in Haematologica (2025-07-01)Get full text
Article -
13
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity by Talha Badar, Yenny A. Moreno Vanegas, Ahmad Nanaa, James M. Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B. Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R. Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M. Patnaik
Published in Blood Cancer Journal (2023-09-01)Get full text
Article -
14
Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: a subset analysis from ECOG-ACRIN 1900 by Hugo F. Fernandez, Zhuoxin Sun, Mark R. Litzow, Selina M. Luger, Elisabeth Paietta, Janis Racevskis, Ross L. Levine, Jay P. Patel, Omar Abdel-Wahab, Rhett P. Ketterling, Gordon W. Dewald, John M. Bennett, Jacob M. Rowe, Hillard M. Lazarus, Martin S. Tallman
Published in Haematologica (2019-04-01)Get full text
Article -
15
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome by Aref Al-Kali, Ahmad Nanaa, David Viswanatha, Rong He, Phuong Nguyen, Dragan Jevremovic, James M. Foran, Cecelia Arana Yi, Patricia T. Greipp, Naseema Gangat, Mrinal Patnaik, Ayalew Tefferi, Mark R. Litzow, Abhishek A. Mangaonkar, Mithun Vinod Shah, Talha Badar, Hassan B. Alkhateeb
Published in Blood Cancer Journal (2023-04-01)Get full text
Article -
16
Clinical and molecular correlates of somatic and germline <i>DDX41</i> variants in patients and families with myeloid neoplasms by Talha Badar, Ahmad Nanaa, James M. Foran, David Viswanatha, Aref Al-Kali, Terra Lasho, Christy Finke, Hassan B Alkhateeb, Rong He, Naseema Gangat, Mithun Shah, Ayalew Tefferi, Abhishek A Mangaonkar, Mark R Litzow, Laura J. Ongie, Timothy Chlon, Alejandro Ferrer, Mrinal M. Patnaik
Published in Haematologica (2023-05-01)Get full text
Article -
17
The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia by John Barrett, Stephen J Forman, Jeffrey S Miller, Jill Brufsky, Jorge Cortes, Marcos de Lima, Michael M Boyiadzis, Ivan Aksentijevich, Daniel A Arber, Renier J Brentjens, Ephraim J Fuchs, Linda J Fukas, Steven D Gore, Mark R Litzow, John M Pagel, Martin S Tallman
Published in Journal for ImmunoTherapy of Cancer (2020-10-01)Get full text
Article -
18
Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival by Ayalew Tefferi, Amritpal Singh, Naseema Gangat, Aref Al-Kali, Hassan Alkhateeb, Mithun Shah, Mrinal S. Patnaik, Michelle A. Elliott, William J. Hogan, Mark R. Litzow, Alexandra Wolanskyj-Spinner, Christopher C. Hook, Abhishek Mangaonkar, David Viswanatha, Dong Chen, Animesh Pardanani, Kebede H. Begna, Rhett P. Ketterling
Published in Haematologica (2022-09-01)Get full text
Article -
19
Prognostic impact of <i>SF3B1</i> mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases by Faiqa Farrukh, Maymona Abdelmagid, Abhishek Mangaonkar, Mrinal Patnaik, Aref Al-Kali, Michelle A. Elliott, Kebede H. Begna, Christopher C. Hook, William J. Hogan, Animesh Pardanani, Mark R. Litzow, Rhett P. Ketterling, Naseema Gangat, Daniel A. Arber, Attilio Orazi, Rong He, Kaaren Reichard, Ayalew Tefferi
Published in Haematologica (2024-03-01)Get full text
Article -
20
Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival by Maymona G. Abdelmagid, Aref Al-Kali, Kebede H. Begna, William J. Hogan, Mark R. Litzow, Farah Fleti, Abhishek A. Mangaonkar, Mrinal S. Patnaik, Michelle A. Elliott, Hassan Alkhateeb, Min Shi, Matthew T. Howard, Kaaren K. Reichard, Rhett P. Ketterling, Mithun Shah, Animesh Pardanani, Naseema Gangat, Ayalew Tefferi
Published in Haematologica (2023-02-01)Get full text
Article